Datwyler and Toxikon Europe NV have announced to further strengthen their partnership in the health care sector. The preclinical contract research organisation has grown to be the number one in analytical services for extractables and leachables in the last ten years and also offers a variety of other testing services, e.g. for medical devices and product development. Since the reduction of extractables and leachables is a main focus in the development of rubber formulations, Toxikon is the ideal partner for Datwyler to further improve its health care offering: Among other products, Datwyler manufactures rubber components for primary packaging for parenterals. The partnership with Toxikon will reduce the time that (bio)-pharmaceutical products incorporating Datwyler components need for scientific and regulatory acceptance. As a result, it will accelerate time-to-market for pharmaceutical and bio-pharmaceutical drugs.